Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Short term Debt (2016 - 2026)

Conmed filings provide 17 years of Short term Debt readings, the most recent being $711000.0 for Q1 2026.

  • On a quarterly basis, Short term Debt changed 0.42% to $711000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $711000.0, a 0.42% change, with the full-year FY2025 number at $712000.0, changed 0.42% from a year prior.
  • Short term Debt hit $711000.0 in Q1 2026 for Conmed, roughly flat from $712000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $70.6 million in Q3 2023 to a low of $237000.0 in Q3 2022.
  • Median Short term Debt over the past 5 years was $715000.0 (2024), compared with a mean of $17.6 million.
  • Biggest five-year swings in Short term Debt: surged 29699.58% in 2023 and later tumbled 99.01% in 2024.
  • Conmed's Short term Debt stood at $69.7 million in 2022, then plummeted by 98.98% to $708000.0 in 2023, then increased by 0.99% to $715000.0 in 2024, then decreased by 0.42% to $712000.0 in 2025, then dropped by 0.14% to $711000.0 in 2026.
  • The last three reported values for Short term Debt were $711000.0 (Q1 2026), $712000.0 (Q4 2025), and $746000.0 (Q3 2025) per Business Quant data.